Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

Most hair loss in children is caused by a few common conditions and is easy to diagnose, but rare types require careful evaluation.

People with vitiligo are more likely to also have alopecia areata.

Toxic metals can cause hair loss and should be considered by doctors.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

A woman with Kallman's syndrome also developed alopecia universalis, a condition not previously linked to Kallman's.

Alopecia areata is decreasing globally, affects more females, and is linked to anxiety and atopic dermatitis, especially in children.

Dupilumab users have a higher risk of developing alopecia areata.

Hair loss in alopecia areata can negatively affect sexual quality of life.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Dithranol is more effective than Tacrolimus for hair regrowth in alopecia areata.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Baricitinib shows promise for treating alopecia areata with mild side effects.

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

Individualized treatment and psychological support are crucial for alopecia.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

People with atopic dermatitis have a higher risk of developing autoimmune diseases.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.